CLINICAL_TRIALS
trial_result
· 2019-07-12
Clinical Trial Update: Subcutaneous Lidocaine For Cancer-Related Pain [Phase 2, Phase 3]
Summary
Phase 2/3 trial updates subcutaneous lidocaine for cancer-related pain; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: British Columbia Cancer Agency | Conditions: Cancer-related Pain | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-07-12